The inhibition of HK2 knockdown not only impeded the tumorigenic growth of glioblastoma, medulloblastoma, and renal cell carcinoma [77–79], but also demonstrated anti-angiogenic effects in pancreatic cancer cells [80]. The gene discussed is HK2; the disease is pancreatic neoplasm.